https://www.selleckchem.com/pr....oducts/acss2-inhibit
42 in patients and -3.65 to 4.59 in healthy controls. Conclusion The MAT has a good reliability in patients with head and neck cancer and a moderate reliability in healthy controls.FoxA2 is an essential transcription factor for liver organogenesis and homeostasis. Although reduced expression of FoxA2 has been associated with chronic liver diseases, hepatic progenitor cells (HPCs) that are activated in these circumstances express FoxA2. However, the functional effects and underlying mechanism of FoxA2 in HPCs are still unknown. A
Like
Comment
Share